belimumab   Click here for help

GtoPdb Ligand ID: 6887

Synonyms: Benlysta® | hBlySmAb-1.1 | LimphoStat-B | lymphostat-B
Approved drug Immunopharmacology Ligand
belimumab is an approved drug (FDA (2011), EMA (2011))
Compound class: Antibody
Comment: Belimumab is a monoclonal antibody targeting TNFSF13B (BAFF; BLyS) [1,5] , an immunostimulant essential for normal B cell maintenance and humoral immunity [6], and which is reported to be elevated in systemic lupus erythematosus (SLE) and other autoimmune diseases.
Immunopharmacology Comments
Suppresses B-cell mediated immunity in autoimmune diseases.
Immunopharmacology Disease
Disease X-Refs Comment References
Systemic lupus erythematosus Disease Ontology: DOID:9074
OMIM: 152700
Orphanet: ORPHA536
Approved drug for SLE.
Sjögren's syndrome Orphanet: ORPHA378
In clinical trial for this indication- see NCT02631538, in combination with rituximab.
Vasculitis Disease Ontology: DOID:865
In clinical trial for this indication- see NCT01663623.
Myositis Disease Ontology: DOID:633
OMIM: 160750
In clinical trial for this indication- see NCT02347891.